Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    Bulgaria Czechia France Germany Greece Italy +2
  • Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Czechia Poland
  • Study on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland
  • Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Germany Hungary Poland +1
  • Study of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Austria Czechia France Germany Hungary Poland +1
  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Czechia Denmark Italy Portugal Spain +1
  • Study on the Safety and Effectiveness of ADX-914 for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Denmark France Italy Spain Sweden
  • Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    France Germany Greece Poland
  • Study on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Hungary Poland Spain